Patent ID: 9696308
Date: 2017-07-04
CPC Classifications: C07K,C12N,C12Q,G01N

Claim:
1. A method of diagnosing malignant lymphoproliferation associated with a replicative form of Epstein-Barr virus (EBV) or with a tumor associated with EBV, in a patient seropositive for EBV, said process comprising: wherein in said sandwich ELISA, AZ125 antibody is absorbed on a suitable plate to capture the soluble circulating protein complex, and AZ130 antibody is used for detecting the protein complex captured by the AZ125 antibody; wherein a measured amount of said soluble circulating protein complex greater than or equal to 0.15 micrograms/ml of biological body fluid indicates said patient having said malignant lymphoproliferation.